Advertisement
Journal Home
Search for

Issue

Alert me when new journal issues are available via Request RSS feed of current issue

previous issue next issue

European Journal of Cancer
Volume 39, Issue 13, Pages 1811-1966 (September 2003)

display abstract citation download email a colleague
Display:

Review


New non-angiogenesis dependent pathways for tumour growth
D. Ribatti, A. Vacca, F. Dammacco
pages 1835-1841
Abstract | Full Text | Full-Text PDF (138 KB)


The personality and quality of life in HNSCC patients following treatment
H.J Aarstad, A.K.H Aarstad, E.J Birkhaug, E Bru, J Olofsson
pages 1852-1860
Abstract | Full Text | Full-Text PDF (245 KB)


Interobserver reproducibility of ulceration assessment in primary cutaneous melanomas
A Spatz, M.G Cook, D.E Elder, M Piepkorn, D.J Ruiter, R.L Barnhill, on behalf of the EORTC Melanoma group
pages 1861-1865
Abstract | Full Text | Full-Text PDF (211 KB)


Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract
E. Winquist, D.S. Ernst, D. Jonker, M.J. Moore, R. Segal, G. Lockwood, A. Rodgers
pages 1866-1871
Abstract | Full Text | Full-Text PDF (161 KB)


Tumour markers are poor predictors for relapse or progression in neuroblastoma
T. Simon, B. Hero, D.H. Hunneman, F. Berthold
pages 1899-1903
Abstract | Full Text | Full-Text PDF (130 KB)


Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro
I. Recchia, N. Rucci, C. Festuccia, M. Bologna, A.R. MacKay, S. Migliaccio, M. Longo, M. Šuša, D. Fabbro, A. Teti
pages 1927-1935
Abstract | Full Text | Full-Text PDF (359 KB)


Familial relative risk of colorectal cancer: a population-based study
N. Andrieu, G. Launoy, R. Guillois, C. Ory-Paoletti, M. Gignoux
pages 1904-1911
Abstract | Full Text | Full-Text PDF (228 KB)


Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma
L Manenti, P Paganoni, I Floriani, F Landoni, V Torri, A Buda, G Taraboletti, R Labianca, D Belotti, R Giavazzi
pages 1948-1956
Abstract | Full Text | Full-Text PDF (259 KB)


Gene expression profiles in human non-small and small-cell lung cancers
S. Difilippantonio, Y. Chen, A. Pietas, K. Schlüns, M. Pacyna-Gengelbach, N. Deutschmann, H.M. Padilla-Nash, T. Ried, I. Petersen
pages 1936-1947
Abstract | Full Text | Full-Text PDF (226 KB)


The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR
T.-S. Wong, M.W.-L. Man, A.K.-Y. Lam, W.I. Wei, Y.-L. Kwong, A.P.-W. Yuen
pages 1881-1887
Abstract | Full Text | Full-Text PDF (407 KB)


Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities?
K. Khanfir, L. Alzieu, P. Terrier, C. Le Péchoux, S. Bonvalot, D. Vanel, A. Le Cesne
pages 1872-1880
Abstract | Full Text | Full-Text PDF (199 KB)


Differential relationship between changes in tumour size and microcirculatory functions induced by therapy with an antivascular drug and with cytotoxic drugs: implications for the evaluation of therapeutic efficacy of AC7700 (AVE8062)
K. Hori, S. Saito, Y. Sato, H. Akita, T. Kawaguchi, K. Sugiyama, H. Sato
pages 1957-1966
Abstract | Full Text | Full-Text PDF (507 KB)


The influence of dietary patterns on the development of thyroid cancer
I Markaki, D Linos, A Linos
pages 1912-1919
Abstract | Full Text | Full-Text PDF (196 KB)


Oncological research overview in the European Union. A 5-year survey
D. Ugolini, G.S. Mela
pages 1888-1894
Abstract | Full Text | Full-Text PDF (422 KB)

Editorial Comment


Rationale for drug combinations
J.F. Smyth
pages 1816-1817
Full Text | Full-Text PDF (62 KB)

Current Perspective


Small molecules that reactivate mutant p53
V.J.N. Bykov, G. Selivanova, K.G. Wiman
pages 1828-1834
Abstract | Full Text | Full-Text PDF (220 KB)


Phase I and pharmacokinetic study of Yondelis™ (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours
C. Twelves, K. Hoekman, A. Bowman, J.B. Vermorken, A. Anthoney, J. Smyth, C. van Kesteren, J.H. Beijnen, J. Uiters, J. Wanders, J. Gomez, C. Guzmán, J. Jimeno, A. Hanauske, for the New Drug Development Group of the EORTC
pages 1842-1851
Abstract | Full Text | Full-Text PDF (279 KB)


Impact of the treating institution on the survival of patients with head and neck cancer treated with concomitant alternating chemotherapy and radiation
M. Benasso, R. Lionetto, R. Corvò, A. Ponzanelli, V. Vitale, R. Rosso
pages 1895-1898
Abstract | Full Text | Full-Text PDF (170 KB)


The combination of yondelis and cisplatin is synergistic against human tumor xenografts
M. D'Incalci, T. Colombo, P. Ubezio, I. Nicoletti, R. Giavazzi, E. Erba, L. Ferrarese, D. Meco, R. Riccardi, C. Sessa, E. Cavallini, J. Jimeno, G.T. Faircloth
pages 1920-1926
Abstract | Full Text | Full-Text PDF (198 KB)

Position Paper


Current research and treatment for epithelial ovarian cancer A Position Paper from the Helene Harris Memorial Trust
F. Balkwill, R.C. Bast, J. Berek, G. Chenevix-Trench, M. Gore, T. Hamilton, I. Jacobs, G. Mills, R. Souhami, N. Urban, S. Ursulic, J. Smyth
pages 1818-1827
Abstract | Full Text | Full-Text PDF (184 KB)



pages ix-x
Full-Text PDF (62 KB)



pages 1811-1815
Full-Text PDF (206 KB)


Editorial board
page ii
Full-Text PDF (30 KB)


Calendar
pages I-II
Full-Text PDF (27 KB)

display abstract citation download email a colleague
Display:
Advertisement